About this Research Topic
Cardiovascular diseases (CVDs) are the leading cause of mortality worldwide. About 17.9 million people died from CVDs in 2019, which is representing 32% of all global deaths. In recent years, the striking development of molecular and cellular biology, especially genetics, stem cell biology, and developmental biology are transforming the way we understand and treat heart failure.
Our aim is for this Special Issue to provide a platform to attest new therapeutic interventions targeting failing heart, and promoting novel diagnostic and therapeutic strategies for the failing heart.
In this Special Issue, we invite cardiologists, cardiovascular surgeons, geneticists, and cell
and developmental biologists to submit original research papers or reviewers on treatment
and mechanism associated with heart failure. Topics include but are not limited to genetics, genome editing, stem cells, drug development, next-generation DNA and RNA sequencing, advances of new or novel clinical treatments.
Our aim is for this Special Issue to provide a platform to attest new therapeutic interventions targeting failing heart, and promoting novel diagnostic and therapeutic strategies for the failing heart.
In this Special Issue, we invite cardiologists, cardiovascular surgeons, geneticists, and cell
and developmental biologists to submit original research papers or reviewers on treatment
and mechanism associated with heart failure. Topics include but are not limited to genetics, genome editing, stem cells, drug development, next-generation DNA and RNA sequencing, advances of new or novel clinical treatments.
Keywords: Therapeutics, Basic Science, Translational Science, Clinical Science, Cardiovascular diseases.
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
